Alpha DNA Investment Management LLC Buys Shares of 9,023 Trupanion, Inc. (NASDAQ:TRUP)

Alpha DNA Investment Management LLC bought a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 9,023 shares of the financial services provider's stock, valued at approximately $435,000.

A number of other hedge funds have also made changes to their positions in the stock. Baillie Gifford & Co. boosted its stake in Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after acquiring an additional 147,341 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Trupanion by 458.3% during the fourth quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider's stock worth $7,620,000 after purchasing an additional 129,782 shares during the last quarter. Invesco Ltd. lifted its position in shares of Trupanion by 122.0% during the fourth quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider's stock worth $10,925,000 after purchasing an additional 124,549 shares during the last quarter. Trexquant Investment LP grew its stake in Trupanion by 229.3% in the fourth quarter. Trexquant Investment LP now owns 138,109 shares of the financial services provider's stock worth $6,657,000 after purchasing an additional 96,174 shares in the last quarter. Finally, Hosking Partners LLP increased its holdings in Trupanion by 52.5% in the fourth quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider's stock valued at $10,253,000 after buying an additional 73,203 shares during the last quarter.

Analyst Ratings Changes

TRUP has been the subject of several research reports. Stifel Nicolaus decreased their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday, February 20th. Piper Sandler reduced their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $46.60.

Trupanion Price Performance

Shares of TRUP stock traded up $0.79 during midday trading on Thursday, reaching $36.47. 121,237 shares of the company were exchanged, compared to its average volume of 651,373. The company's 50 day moving average price is $35.90 and its two-hundred day moving average price is $45.38. The company has a market cap of $1.55 billion, a P/E ratio of -158.36, a PEG ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. On average, sell-side analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In other news, SVP Emily Dreyer sold 14,025 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the sale, the senior vice president now directly owns 27,645 shares of the company's stock, valued at $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Brenna Mcgibney sold 5,000 shares of Trupanion stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $164,950.00. Following the completion of the transaction, the insider now directly owns 3,738 shares in the company, valued at $123,316.62. This represents a 57.22 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 33,792 shares of company stock valued at $1,122,802. 5.50% of the stock is owned by insiders.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.